Semler Scientific, Inc. develops, manufactures, and markets proprietary products that assist healthcare providers to evaluate and treat patients with chronic diseases in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. Its products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, and family practitioners, as well as healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups. The company offers its products through salespersons and distributors. Semler Scientific, Inc. was incorporated in 2007 and is headquartered in Santa Clara, California.
IPO Year:
Exchange: NASDAQ
Website: semlerscientific.com
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 11/2/2022 | $60.00 → $45.00 | Buy → Neutral | B. Riley Securities |
| 3/7/2022 | $145.00 → $70.00 | Buy | B. Riley Securities |
| 11/2/2021 | $175.00 → $145.00 | Buy | B. Riley Securities |
| 10/26/2021 | $151.00 → $175.00 | Buy | B. Riley Securities |
CAMPBELL, Calif., May 19, 2025 /PRNewswire/ -- Semler Scientific, Inc. (NASDAQ:SMLR), a publicly traded company that has adopted Bitcoin as its primary treasury reserve asset and is one of the leading corporate holders of Bitcoin, announced the appointment of Natalie Brunell to its board of directors. This strategic addition reflects Semler Scientific's continued commitment to its Bitcoin treasury strategy and further strengthens its leadership within the Bitcoin community. "We are thrilled to welcome Natalie to our board of directors," said Eric Semler, chairman of Semler Sci
CAMPBELL, Calif., May 13, 2025 /PRNewswire/ -- Semler Scientific, Inc. (NASDAQ:SMLR), a publicly traded company that has adopted bitcoin as its primary treasury reserve asset and is one of the leading corporate holders of bitcoin, today reported financial results for the first quarter ended March 31, 2025 and provided an update on its bitcoin holdings and other key performance indicators (KPIs). "We continue to accretively grow our bitcoin arsenal using operating cash flow and proceeds from debt and equity financings," said Eric Semler, chairman of Semler Scientific. "And we a
SANTA CLARA, Calif., April 30, 2025 /PRNewswire/ -- Semler Scientific, Inc. (NASDAQ:SMLR), a publicly traded company that has adopted bitcoin as its primary treasury reserve asset and is one of the leading corporate holders of bitcoin, today announced updates regarding its bitcoin (BTC) activity, holdings and yield, its at-the-market equity offering (ATM) program and first quarter earnings release date and conference call. BTC Update Between April 25, 2025 and April 29, 2025, Semler Scientific acquired 165 bitcoins for $15.7 million with an average purchase price of $94,931 pe
SANTA CLARA, Calif., April 25, 2025 /PRNewswire/ -- Semler Scientific, Inc. (NASDAQ:SMLR), a pioneer in developing and marketing technology products and services to assist its customers in evaluating and treating chronic diseases, today announced updates regarding its bitcoin (BTC) activity, holdings and yield, as well as its at-the-market equity offering (ATM) programs. BTC Update Between February 14, 2025 and April 24, 2025, Semler Scientific acquired 111 bitcoins for $10.0 million with an average purchase price of $90,124 per bitcoin, inclusive of fees and expenses, using p
SANTA CLARA, Calif., Feb. 18, 2025 /PRNewswire/ -- Semler Scientific, Inc. (NASDAQ:SMLR), a pioneer in developing and marketing technology products and services to healthcare providers to combat chronic diseases, today reported financial results for the fourth quarter and year ended December 31, 2024. "We are again pleased to report strong performance from our healthcare business with income from operations of $20.9 million for the full year 2024," said Doug Murphy-Chutorian, MD, chief executive officer of Semler Scientific. "While we continue to support innovation and growth
SANTA CLARA, Calif., Feb. 4, 2025 /PRNewswire/ -- Semler Scientific, Inc. (NASDAQ:SMLR), a pioneer in developing and marketing technology products and services to assist its customers in evaluating and treating chronic diseases, today announced updates regarding its bitcoin (BTC) activity and holdings, and BTC Yield, a key performance indicator. BTC Update Between January 11, 2025 and February 3, 2025, Semler Scientific acquired 871 bitcoins for $88.5 million with proceeds generated from its January 2025 senior convertible notes offering and monetization of a portion of its mi
SANTA CLARA, Calif., Jan. 24, 2025 /PRNewswire/ -- Semler Scientific, Inc. (NASDAQ:SMLR) today announced the pricing of its offering of $85.0 million aggregate principal amount of 4.25% convertible senior notes due 2030 (the "notes") in a private offering (the "offering") to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). The offering size was increased from the previously announced offering size of $75.0 million aggregate principal amount of notes. Semler Scientific also granted the initial purchasers of the notes an option to purchase, during a 13-day period beginning on, and includi
SANTA CLARA, Calif., Jan. 23, 2025 /PRNewswire/ -- Semler Scientific, Inc. (NASDAQ:SMLR), a pioneer in developing and marketing technology products and services to healthcare providers to combat chronic diseases, today announced select preliminary unaudited fourth quarter 2024 financial results and BTC holdings. Semler Scientific will report full financial results for the fourth quarter and full year ended December 31, 2024, as well as provide an update on its Bitcoin holdings after the close of U.S. financial markets on Tuesday, February 18, 2025. Select Preliminary Unaudited
SANTA CLARA, Calif., Jan. 23, 2025 /PRNewswire/ -- Semler Scientific, Inc. (NASDAQ:SMLR) today announced that it intends to offer, subject to market conditions and other factors, $75.0 million aggregate principal amount of convertible senior notes due 2030 (the "notes") in a private offering (the "offering") to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act"). Semler Scientific also intends to grant the initial purchasers of the notes an option to purchase, during a 13-day period beginning on, and including, the first date on which the notes are issued, up to an additional $15.0 million
SANTA CLARA, Calif., Jan. 13, 2025 /PRNewswire/ -- Semler Scientific, Inc. (NASDAQ:SMLR), a pioneer in developing and marketing technology products and services to healthcare providers to combat chronic diseases, today announced updates regarding its bitcoin (BTC) activity and holdings, capital markets activity, and BTC Yield, a key performance indicator. BTC Update Between December 16, 2024 and January 10, 2025, Semler Scientific acquired 237 bitcoins for $23.3 million with proceeds generated from its at-the-market (ATM) offering and operating cash flow at an average price of
4 - Semler Scientific, Inc. (0001554859) (Issuer)
CAMPBELL, Calif., May 13, 2025 /PRNewswire/ -- Semler Scientific, Inc. (NASDAQ:SMLR), a publicly traded company that has adopted bitcoin as its primary treasury reserve asset and is one of the leading corporate holders of bitcoin, today reported financial results for the first quarter ended March 31, 2025 and provided an update on its bitcoin holdings and other key performance indicators (KPIs). "We continue to accretively grow our bitcoin arsenal using operating cash flow and proceeds from debt and equity financings," said Eric Semler, chairman of Semler Scientific. "And we a
SANTA CLARA, Calif., April 30, 2025 /PRNewswire/ -- Semler Scientific, Inc. (NASDAQ:SMLR), a publicly traded company that has adopted bitcoin as its primary treasury reserve asset and is one of the leading corporate holders of bitcoin, today announced updates regarding its bitcoin (BTC) activity, holdings and yield, its at-the-market equity offering (ATM) program and first quarter earnings release date and conference call. BTC Update Between April 25, 2025 and April 29, 2025, Semler Scientific acquired 165 bitcoins for $15.7 million with an average purchase price of $94,931 pe
SANTA CLARA, Calif., April 25, 2025 /PRNewswire/ -- Semler Scientific, Inc. (NASDAQ:SMLR), a pioneer in developing and marketing technology products and services to assist its customers in evaluating and treating chronic diseases, today announced updates regarding its bitcoin (BTC) activity, holdings and yield, as well as its at-the-market equity offering (ATM) programs. BTC Update Between February 14, 2025 and April 24, 2025, Semler Scientific acquired 111 bitcoins for $10.0 million with an average purchase price of $90,124 per bitcoin, inclusive of fees and expenses, using p
SANTA CLARA, Calif., Feb. 18, 2025 /PRNewswire/ -- Semler Scientific, Inc. (NASDAQ:SMLR), a pioneer in developing and marketing technology products and services to healthcare providers to combat chronic diseases, today reported financial results for the fourth quarter and year ended December 31, 2024. "We are again pleased to report strong performance from our healthcare business with income from operations of $20.9 million for the full year 2024," said Doug Murphy-Chutorian, MD, chief executive officer of Semler Scientific. "While we continue to support innovation and growth
SANTA CLARA, Calif., Feb. 4, 2025 /PRNewswire/ -- Semler Scientific, Inc. (NASDAQ:SMLR), a pioneer in developing and marketing technology products and services to assist its customers in evaluating and treating chronic diseases, today announced updates regarding its bitcoin (BTC) activity and holdings, and BTC Yield, a key performance indicator. BTC Update Between January 11, 2025 and February 3, 2025, Semler Scientific acquired 871 bitcoins for $88.5 million with proceeds generated from its January 2025 senior convertible notes offering and monetization of a portion of its mi
SANTA CLARA, Calif., Jan. 23, 2025 /PRNewswire/ -- Semler Scientific, Inc. (NASDAQ:SMLR), a pioneer in developing and marketing technology products and services to healthcare providers to combat chronic diseases, today announced select preliminary unaudited fourth quarter 2024 financial results and BTC holdings. Semler Scientific will report full financial results for the fourth quarter and full year ended December 31, 2024, as well as provide an update on its Bitcoin holdings after the close of U.S. financial markets on Tuesday, February 18, 2025. Select Preliminary Unaudited
SANTA CLARA, Calif., Jan. 13, 2025 /PRNewswire/ -- Semler Scientific, Inc. (NASDAQ:SMLR), a pioneer in developing and marketing technology products and services to healthcare providers to combat chronic diseases, today announced updates regarding its bitcoin (BTC) activity and holdings, capital markets activity, and BTC Yield, a key performance indicator. BTC Update Between December 16, 2024 and January 10, 2025, Semler Scientific acquired 237 bitcoins for $23.3 million with proceeds generated from its at-the-market (ATM) offering and operating cash flow at an average price of
SANTA CLARA, Calif., Dec. 16, 2024 /PRNewswire/ -- Semler Scientific, Inc. (NASDAQ:SMLR), a pioneer in developing and marketing technology products and services to healthcare providers to combat chronic diseases, today announced updates regarding its bitcoin (BTC) activity and holdings, capital markets activity, and BTC Yield, a key performance indicator. BTC Update Between December 5, 2024 and December 15, 2024, Semler Scientific acquired 211 bitcoins for $21.5 million with proceeds generated from its at-the-market (ATM) offering and operating cash flow at an average price of
SANTA CLARA, Calif., Dec. 5, 2024 /PRNewswire/ -- Semler Scientific, Inc. (NASDAQ:SMLR), a pioneer in developing and marketing technology products and services to healthcare providers to combat chronic diseases, today announced updates regarding its bitcoin (BTC) activity and holdings, capital markets activity, and BTC Yield, a key performance indicator. BTC Update Between November 25, 2024 and December 4, 2024, Semler Scientific acquired 303 bitcoins for $29.3 million with proceeds generated from its at-the-market (ATM) offering at an average price of $96,779 per bitcoin, inc
- Purchased Additional 297 BTC; Now Holds 1,570 BTC; BTC Yield of 58.4% - - Launches Additional $50.0 million ATM - SANTA CLARA, Calif., Nov. 25, 2024 /PRNewswire/ -- Semler Scientific, Inc. (NASDAQ:SMLR), a pioneer in developing and marketing technology products and services to healthcare providers to combat chronic diseases, today announced updates regarding its bitcoin (BTC) activity and holdings, capital markets activity, and BTC yield, a key performance indicator. BTC Update Between November 18, 2024 and November 22, 2024, Semler Scientific acquired 297 bitcoins for $29.1
4 - Semler Scientific, Inc. (0001554859) (Issuer)
3 - Semler Scientific, Inc. (0001554859) (Issuer)
4 - Semler Scientific, Inc. (0001554859) (Issuer)
4 - Semler Scientific, Inc. (0001554859) (Issuer)
4 - Semler Scientific, Inc. (0001554859) (Issuer)
4 - Semler Scientific, Inc. (0001554859) (Issuer)
4 - Semler Scientific, Inc. (0001554859) (Issuer)
4 - Semler Scientific, Inc. (0001554859) (Issuer)
4 - Semler Scientific, Inc. (0001554859) (Issuer)
4/A - Semler Scientific, Inc. (0001554859) (Issuer)
CAMPBELL, Calif., May 19, 2025 /PRNewswire/ -- Semler Scientific, Inc. (NASDAQ:SMLR), a publicly traded company that has adopted Bitcoin as its primary treasury reserve asset and is one of the leading corporate holders of Bitcoin, announced the appointment of Natalie Brunell to its board of directors. This strategic addition reflects Semler Scientific's continued commitment to its Bitcoin treasury strategy and further strengthens its leadership within the Bitcoin community. "We are thrilled to welcome Natalie to our board of directors," said Eric Semler, chairman of Semler Sci
SANTA CLARA, Calif., July 11, 2023 /PRNewswire/ -- Semler Scientific, Inc. (NASDAQ:SMLR), a company that develops, manufactures and markets innovative medical products and services that assist in evaluating and treating chronic diseases, today announced the appointment of a chief financial officer (CFO), record quarterly revenues expected for the second quarter of 2023 and a strategic streamlining. "We are pleased to announce Ms. Renae Cormier will lead our accounting, finance, investor relations and business strategy efforts as chief financial officer," said Doug Murphy-Chuto
Eric Semler Appointed as Chairman SANTA CLARA, Calif., April 19, 2023 /PRNewswire/ -- - Semler Scientific, Inc. (NASDAQ:SMLR) today announced that Eric Semler and William H.C. Chang (together, the "Investors"), who collectively beneficially own more than 20% of Semler Scientific's outstanding shares, will immediately join Semler Scientific's board of directors as new independent directors. Mr. Semler will join the board as a Class II director standing for reelection at the 2023 annual meeting of stockholders and will be appointed as Chairman of the board, and Mr. Chang will join the board as a Class I director standing for reelection at the 2025 annual meeting of stockholders. The board will
SANTA CLARA, Calif., March 21, 2023 /PRNewswire/ -- Semler Scientific, Inc. (NASDAQ:SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, announces that Doug Murphy-Chutorian, M.D. has informed the board of directors of his intention to step down from his position as chief executive officer (CEO) of Semler Scientific and assist for a transition period. He will continue to serve as a member of the board of directors at least through the remainder of his 2024 term. "I am proud of the business that we hav
B. Riley Securities downgraded Semler Scientific from Buy to Neutral and set a new price target of $45.00 from $60.00 previously
B. Riley Securities reiterated coverage of Semler Scientific with a rating of Buy and set a new price target of $70.00 from $145.00 previously
B. Riley Securities reiterated coverage of Semler Scientific with a rating of Buy and set a new price target of $145.00 from $175.00 previously
B. Riley Securities reiterated coverage of Semler Scientific with a rating of Buy and set a new price target of $175.00 from $151.00 previously
SC 13D/A - Semler Scientific, Inc. (0001554859) (Subject)
SC 13G - Semler Scientific, Inc. (0001554859) (Subject)
SC 13D/A - Semler Scientific, Inc. (0001554859) (Subject)
SC 13G/A - Semler Scientific, Inc. (0001554859) (Subject)
SC 13G/A - Semler Scientific, Inc. (0001554859) (Subject)
SC 13D/A - Semler Scientific, Inc. (0001554859) (Subject)
SC 13D/A - Semler Scientific, Inc. (0001554859) (Subject)
SC 13D/A - Semler Scientific, Inc. (0001554859) (Subject)
SC 13D/A - Semler Scientific, Inc. (0001554859) (Subject)
SC 13G - Semler Scientific, Inc. (0001554859) (Subject)
8-K - Semler Scientific, Inc. (0001554859) (Filer)
8-K - Semler Scientific, Inc. (0001554859) (Filer)
8-K - Semler Scientific, Inc. (0001554859) (Filer)
8-K - Semler Scientific, Inc. (0001554859) (Filer)
10-Q - Semler Scientific, Inc. (0001554859) (Filer)
8-K - Semler Scientific, Inc. (0001554859) (Filer)
8-K - Semler Scientific, Inc. (0001554859) (Filer)
8-K - Semler Scientific, Inc. (0001554859) (Filer)
8-K - Semler Scientific, Inc. (0001554859) (Filer)
EFFECT - Semler Scientific, Inc. (0001554859) (Filer)